Brevan Howard Capital Management LP Iqvia Holdings Inc. Transaction History

Brevan Howard Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$137.0 - $174.37 $6.04 Million - $7.69 Million	44,102 Added 195.14%	66,702 $10.5 Million
Q1 2025 May 15, 2025	BUY	$176.3 - $209.96 $622,691 - $741,578	3,532 Added 18.52%	22,600 $3.98 Million
Q4 2024 Feb 14, 2025	SELL	$190.97 - $236.63 $670,113 - $830,334	-3,509 Reduced 15.54%	19,068 $3.75 Million
Q3 2024 Nov 14, 2024	SELL	$206.81 - $251.55 $1.07 Million - $1.3 Million	-5,162 Reduced 18.61%	22,577 $5.35 Million
Q2 2024 Aug 14, 2024	BUY	$211.18 - $248.87 $5.86 Million - $6.9 Million	27,739 New	27,739 $5.87 Million

Q4 2023 Feb 14, 2024	BUY	$177.16 - $232.73 $218,261 - $286,723	1,232 Added 130.23%	2,178 $503,000
Q2 2023 Aug 14, 2023	BUY	$183.66 - $224.77 $173,742 - $212,632	946 New	946 $212,000

1,180

159M

2.51M

1.18M

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $41B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Brevan Howard Capital Management LP with notifications on news.